Medifast Schedules Q4 and Full-Year 2025 Earnings Release
Event summary
- Medifast (NYSE: MED) will release Q4 and full-year 2025 financial results on February 17, 2026, after market close.
- Conference call scheduled for 4:30 p.m. ET on February 17, 2026, featuring CEO Dan Chard, President Nick Johnson, and CFO Jim Maloney.
- Live broadcast available via Medifast's Investor Relations website and Viavid webcast link.
- Telephonic playback available from February 17 to February 24, 2026.
The big picture
Medifast's upcoming earnings release comes at a critical juncture as the health and wellness industry faces heightened competition and shifting consumer preferences. The company's focus on metabolic health and its proprietary Metabolic Synchronization™ technology positions it uniquely, but its ability to translate these innovations into sustained financial performance will be under scrutiny. Investors will be watching closely to see if Medifast can maintain its growth momentum and operational efficiency in a rapidly evolving market.
What we're watching
- Revenue Growth
- Whether Medifast can sustain its growth trajectory amid increasing competition in the health and wellness sector.
- Operational Efficiency
- How cost management and operational efficiencies will impact profitability in 2026.
- Market Positioning
- The pace at which Medifast can expand its market share through its science-backed, coach-guided lifestyle system.
Related topics